Legislative requirements for handling drugs, including the prescribing and supply of drugs of addiction and restricted substances
Other guides
New South Wales Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment of Opioid Dependence
Please note the following regulatory guidelines have been rescinded:
- Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Children and Adolescents (TG181).
- Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Adults (TG190).
Refer to Prescribe a psychostimulant medication for more information.
